Actively Recruiting
Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and No Antibiotic Treatment
Led by Katarina Hedin · Updated on 2024-12-04
260
Participants Needed
6
Research Sites
351 weeks
Total Duration
On this page
Sponsors
K
Katarina Hedin
Lead Sponsor
U
Umeå University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Sore throat is the second most common cause of antibiotic prescribing in primary care in Sweden. Guidelines for sore throat focus on identifying people with sore throat where there are 3 and 4 specified criteria and where near patient tests identify group A streptococci (GAS). In these cases, phenoxymethylpenicillin is recommended. Studies that have identified microorganisms in sore throat show that there are other bacteria and viruses than GAS, that give similar symptoms and that sometimes no microorganism is trapped despite pronounced symptoms. In recent years, a bacterium F. necrophorum has been identified, which is found in increased incidence of sore throat, but it is also found in healthy individuals. In clinical practice, many patients are treated with penicillin even if GAS is not captured. This may be because the doctor perceives the patient as sick or because other bacteria are not caught with a near patient test which causes the doctor to treat anyway. The specific aims are to in patients with GAS-negative sore throat and 3 and 4 criteria, aged 15 years and older in primary care, study whether phenoxymethylpenicillin treatment shortens the duration of the disease, reduces the symptom intensity and sickness absence, and investigates the importance of other microorganisms than GAS in sore throat. The study is a randomized controlled trial in which patients with sore throat are randomized to phenoxymethylpenicillin 3 times daily for 10 days or to no antibiotic therapy. There will also be and a reference group with severe (Centor score 3-4), GAS-positive acute tonsillitis. Blood samples for inflammatory and immunological response to infections are taken. Throat samples for culture of F. necrophorum and streptococcal groups C and G, as well as polymerase chain reaction (PCR) analysis for bacteria and viruses are also taken at inclusion and at follow-up. The outcome will be followed in a patient diary for 10 days and at a return visit after 18-24 days where the clinical outcome is asked for and where the blood- and throat samples are repeated. Follow-up will also takes place via e-mail after 1 and 3 months.
CONDITIONS
Official Title
Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and No Antibiotic Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Centor score 3-4: no cough, fever over 38.5°C, tender cervical lymph nodes, and tonsillar exudates
- Symptoms lasting less than 8 days
- Negative rapid antigen test for group A streptococci (GAS)
- Willing and able to give informed consent; participants under 18 need consent from both parents or caretakers
You will not qualify if you...
- Currently taking antibiotic treatment
- Known or suspected allergy to phenoxymethylpenicillin
- Suspected peritonsillar abscess or need for hospital admission
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Vårdcentralen Rosenhälsan
Jönköping, Sweden, 551 85
Actively Recruiting
2
Vårdcentralen Kärna
Linköping, Sweden, 586 62
Actively Recruiting
3
Vårdcentralen Lundbergsgatan
Malmö, Sweden, 217 51
Actively Recruiting
4
Mariehems hälsocentral
Umeå, Sweden, 906 51
Not Yet Recruiting
5
Ålidhems hälsocentral
Umeå, Sweden, 907 36
Not Yet Recruiting
6
Vårdcentralen Skärvet
Vaxjo, Sweden, 352 36
Actively Recruiting
Research Team
K
Katarina Hedin, Ass Prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here